13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2015-06-30, filed 2015-08-13, with 59 holding rows worth $994,105,000.
- Accession
- 0001144204-15-049028
- Filer
- CIK 1346824
- Filed
- 2015-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2015
A holdings report, 59 entries on the cover page, a total value of $994,105,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $994,105,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AXOVANT SCIENCES LTD | G0750W104 | COM | 5,000,000 | $101,900,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 9,945,997 | $88,122,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 2,703,093 | $71,632,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 6,000,000 | $66,540,000 | thousands by filing date | call |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 3,302,213 | $54,784,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 3,790,476 | $41,544,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 1,380,320 | $39,891,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,605,361 | $38,898,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,428,571 | $33,879,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,913,153 | $33,825,000 | thousands by filing date | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 1,545,410 | $27,570,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 1,719,945 | $27,468,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 1,506,872 | $26,913,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 1,075,410 | $23,627,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 878,348 | $23,267,000 | thousands by filing date | |
| BELLICUM PHARMACEUTICALS INC | 079481107 | COM | 1,026,402 | $21,832,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 705,925 | $20,197,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 109,383 | $18,417,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 766,000 | $17,944,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 1,141,333 | $16,001,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 1,431,232 | $15,944,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 280,000 | $14,932,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 1,600,000 | $13,808,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 1,220,209 | $13,532,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 749,000 | $13,475,000 | thousands by filing date | |
| THERAPEUTICSMD INC | 88338N107 | COM | 1,680,395 | $13,208,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 1,458,792 | $12,531,000 | thousands by filing date | |
| NIVALIS THERAPEUTICS INC | 65481J109 | COM | 757,263 | $11,473,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 246,645 | $10,236,000 | thousands by filing date | |
| Alcobra Ltd | M2239P109 | SHS | 1,525,894 | $9,979,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 668,406 | $9,953,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 2,670,300 | $9,853,000 | thousands by filing date | |
| SUCAMPO PHARMACEUTICALS-CL A | 864909106 | CL A | 450,000 | $7,394,000 | thousands by filing date | |
| ARCA BIOPHARMA INC | 00211Y209 | COM NEW | 5,678,592 | $6,530,000 | thousands by filing date | |
| AURIS MED HLDG AG | H03579101 | COM | 940,000 | $4,568,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 1,142,676 | $3,451,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 528,118 | $3,306,000 | thousands by filing date | |
| TTOO | 89853L104 | Stock | 138,002 | $2,240,000 | thousands by filing date | |
| VICAL INC | 925602104 | COM | 2,606,978 | $1,825,000 | thousands by filing date | |
| BIOTA PHARMACEUTIALS INC | 090694100 | COM | 807,855 | $1,672,000 | thousands by filing date | |
| MERRIMACK PHARMACEUTICALS IN | 590328100 | COM | 116,400 | $1,439,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 23,500 | $1,382,000 | thousands by filing date | |
| NEWLINK GENETICS CORP | 651511107 | COM | 30,000 | $1,328,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 2,450 | $1,250,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 25,800 | $1,242,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 19,200 | $1,235,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 24,400 | $1,165,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 13,200 | $1,160,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 27,300 | $1,143,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 10,700 | $1,115,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 9,900 | $1,100,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 2,600 | $1,050,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 8,700 | $1,007,000 | thousands by filing date | |
| DURECT CORP | 266605104 | COM | 381,800 | $913,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 126,095 | $909,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 5,900 | $906,000 | thousands by filing date | |
| WAFERGEN BIO-SYSTEMS INC | 93041P308 | Cmn | 205,400 | $647,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 59,200 | $591,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 3,100 | $362,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-15-049028 | this filing | 2015-08-13 | acceptance time not in the bulk data set |